TRANSPLANT RECIPIENT (KIDNEY)
Clinical trials for TRANSPLANT RECIPIENT (KIDNEY) explained in plain language.
Never miss a new study
Get alerted when new TRANSPLANT RECIPIENT (KIDNEY) trials appear
Sign up with your email to follow new studies for TRANSPLANT RECIPIENT (KIDNEY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gene test before kidney transplant could prevent drug dosing errors
Disease control Recruiting nowThis study tests whether checking a patient's genes before a kidney transplant helps doctors give the right dose of tacrolimus, a drug that prevents organ rejection. About 114 people waiting for a kidney transplant will be randomly assigned to either genetic testing or standard c…
Matched conditions: TRANSPLANT RECIPIENT (KIDNEY)
Phase: PHASE4 • Sponsor: Instituto de Investigación Hospital Universitario La Paz • Aim: Disease control
Last updated May 17, 2026 07:36 UTC
-
Could this new treatment free kidney transplant patients from lifelong pills?
Disease control Recruiting nowThis early-phase study tests a treatment called Sip-Tego in 12 adults with kidney failure who are getting a living-donor kidney transplant. The goal is to help the body accept the new kidney so patients can take fewer or even no anti-rejection drugs over time. The study checks sa…
Matched conditions: TRANSPLANT RECIPIENT (KIDNEY)
Phase: EARLY_PHASE1 • Sponsor: Tatsuo Kawai, MD, PhD • Aim: Disease control
Last updated May 15, 2026 11:53 UTC